Late Dislocation of Intraocular Lens (IOL) Following Cataract Surgery: an Evaluation of Two Different Surgical Methods

September 2, 2019 updated by: Marius Dalby, Oslo University Hospital
A prospective randomized study on patients with late in the bag intraocular lens (IOL) dislocation, after cataract surgery. To obtain normal visual function, these patients needs surgery. In this study the investigators will look for advantages and dis-advantages after two different surgical approaches to late in-the-bag IOL dislocation.

Study Overview

Detailed Description

In this prospective, randomized study The investigators will include at least 80 patients with late intraocular lens (IOL) dislocation in the capsular complex, after cataract surgery. To obtain normal visual function, these patients needs surgery. Today, there are two different methods used for this condition; scleral suturing of the capsular complex or exchange of IOL to an iris-fixated IOL (Verisyse). In this study the investigators will look for advantages and dis-advantages for these two methods.

Study Type

Interventional

Enrollment (Actual)

104

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway
        • Oslo University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients with dislocation of IOL in the capsular complex who agree to participate in the study

Exclusion Criteria:

  • patients with total dislocation of the capsular complex'
  • patients with reduced general health
  • patients who can't be randomized

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: IOL repositioning
Operation method: Intraocular lens repositioning by scleral suturing
Other: IOL exchange
Operation method: Intraocular lens exchange with retropupillary iris-claw lens

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Best Corrected Visual Acuity (BCVA)
Time Frame: 6 months, 1 year and 2 years
Measure for visual function. Measured in logMAR
6 months, 1 year and 2 years
Intraocular Pressure (IOP)
Time Frame: 6 months and 2 years
Measure for the pressure inside the eye, measured with Goldman applanation tonometer, in mmHg.
6 months and 2 years
Endothelial Density
Time Frame: 6 months
Corneal endothelial cell density (ECD), measured by confocal microscopy. Reported in cells per square millimeter
6 months
Postoperative Complications
Time Frame: 6 months and 2 years
Cystoid macular edema considered the most important long-term complication and therefore reported here.
6 months and 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Keratometry
Time Frame: 6 months (only analyzed/reported for this time frame)
Keratometry of the cornea. Corneal astigmatism, measured in diopters.
6 months (only analyzed/reported for this time frame)
Questionnaire Visual Function-14 (VF-14) Score
Time Frame: 6 months (only analyzed/reported for this time frame)
Questionnaire considering subjective visual function, scale 0-100 (higher scores mean better subjective visual outcome, lower scores means worse outcome).
6 months (only analyzed/reported for this time frame)
IOL Location
Time Frame: 2 years
Measure IOL's location with slit lamp and Pentacam.
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Liv Drolsum, MD, PhD, Oslo University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

June 1, 2016

Study Completion (Anticipated)

December 1, 2020

Study Registration Dates

First Submitted

January 29, 2013

First Submitted That Met QC Criteria

February 5, 2013

First Posted (Estimate)

February 6, 2013

Study Record Updates

Last Update Posted (Actual)

September 27, 2019

Last Update Submitted That Met QC Criteria

September 2, 2019

Last Verified

September 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intraocular Lens Dislocation

Clinical Trials on Intraocular lens repositioning by scleral suturing

3
Subscribe